FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

9552311000001102: Agalsidase alfa 3.5mg/3.5ml solution for injection vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31104501000001113 Agalsidase alfa 3.5mg/3.5ml solution for injection vials (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
52531301000001110 Agalsidase alfa 3.5mg/3.5ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Is a Agalsidase alfa true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has active ingredient Agalsidase alfa false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has manufactured dose form Solution for injection false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Is a Product containing agalsidase beta false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has active ingredient Alpha-galactosidase false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Is a Product containing agalsidase alfa false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has manufactured dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has specific active ingredient Agalsidase alfa false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has active ingredient Agalsidase alfa false Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has specific active ingredient Agalsidase alfa true Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has manufactured dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) Is a True Agalsidase alfa 3.5mg/3.5ml solution for injection vials Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 10 vial Is pack of False Agalsidase alfa 3.5mg/3.5ml solution for injection vials Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Is pack of False Agalsidase alfa 3.5mg/3.5ml solution for injection vials Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 1 vial Is pack of False Agalsidase alfa 3.5mg/3.5ml solution for injection vials Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 1 vial Has VMP True Agalsidase alfa 3.5mg/3.5ml solution for injection vials Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has VMP True Agalsidase alfa 3.5mg/3.5ml solution for injection vials Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 10 vial Has VMP True Agalsidase alfa 3.5mg/3.5ml solution for injection vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start